Cleared Traditional

K250790 - INNOVISION-DXII (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K250790 · Dk Medical Systems Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2025
Decision
140d
Days
Class 2
Risk

K250790 is an FDA 510(k) clearance for the INNOVISION-DXII. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.

Submitted by Dk Medical Systems Co., Ltd. (Pyeongtaek-Si, KR). The FDA issued a Cleared decision on August 1, 2025 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Dk Medical Systems Co., Ltd. devices

Submission Details

510(k) Number K250790 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 2025
Decision Date August 01, 2025
Days to Decision 140 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 107d · This submission: 140d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPR System, X-ray, Stationary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

KMC, Inc.
DongHa Lee

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KPR System, X-ray, Stationary

All 354
Devices cleared under the same product code (KPR) and FDA review panel - the closest regulatory comparables to K250790.
AeroDR TX c02
K253446 · Dk Medical Systems Co., Ltd. · Apr 2026
DRX-Evolution Plus X-ray System, DRX-Compass Mobile X-ray System, Lux HD 35 detector, Lux HD 43 detector
K250954 · Carestream Health · Jan 2026
uDR Arria & uDR Aris
K252000 · Shanghai United Imaging Healthcare Co., Ltd. · Nov 2025
uDR Aurora CX
K251167 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025
Definium Tempo Select
K250788 · Ge Hualun Medical Systems Co. , Ltd. · Aug 2025
YSIO X.pree
K250738 · Siemens Medical Solutions · Jul 2025